The advent and efficacy of injectable, and now oral, glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro/Zepbound, Eli Lilly and Company) has changed the weight loss landscape forever
And, yes, and Ive got my special prescription
The $180 vial already qualifies for free Costa Rica shipping on its own
Wegovy vs Mounjaro: Side by Side Mechanism Wegovy: GLP-1 receptor agonist Mounjaro: Dual GIP/GLP-1 receptor agonist Dosing Wegovy: Once weekly
Ten trials 13,14,2632 had sufficient data for the meta-analysis (n=366 treatment, n=359 control), and five trials 15,26,3335 were excluded from quantitative synthesis due to incomplete or non-extractable data
Available from: McIntyre RS, Mansur RB, Rosenblat JD, Kwan ATH